Ningbo Menovo Pharm Co Ltd (603538) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.016x

Based on the latest financial reports, Ningbo Menovo Pharm Co Ltd (603538) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥38.86 Million ≈ $5.69 Million USD) by net assets (CN¥2.42 Billion ≈ $353.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Ningbo Menovo Pharm Co Ltd worth for the company's overall valuation and market capitalisation.

Ningbo Menovo Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Ningbo Menovo Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ningbo Menovo Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ningbo Menovo Pharm Co Ltd ranked by their cash flow conversion efficiency. Explore Ningbo Menovo Pharm Co Ltd (603538) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Shandong Denghai Seeds Co Ltd SHE:002041	0.068x
Wuxi Boton Technology Co Ltd SHE:300031	0.008x
Jilin Chemical Fibre Co Ltd SHE:000420	0.011x
Richinfo Technology Co Ltd Class A SHE:300634	-0.014x
Alexander & Baldwin Inc F:ABU	0.024x
Topscore Fashion SHG:603608	0.016x
Alexanders Inc NYSE:ALX	0.075x
JM Financial Limited NSE:JMFINANCIL	-0.028x

Annual Cash Flow Conversion Efficiency for Ningbo Menovo Pharm Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Ningbo Menovo Pharm Co Ltd from 2011 to 2025. View Ningbo Menovo Pharm Co Ltd (603538) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.45 Billion ≈ $358.64 Million	CN¥157.56 Million ≈ $23.06 Million	0.064x	+51.03%
2024-12-31	CN¥2.29 Billion ≈ $335.31 Million	CN¥97.54 Million ≈ $14.27 Million	0.043x	+918.66%
2023-12-31	CN¥2.19 Billion ≈ $319.83 Million	CN¥9.13 Million ≈ $1.34 Million	0.004x	-96.72%
2022-12-31	CN¥2.17 Billion ≈ $318.01 Million	CN¥276.95 Million ≈ $40.53 Million	0.127x	+14.28%
2021-12-31	CN¥1.98 Billion ≈ $289.52 Million	CN¥220.63 Million ≈ $32.28 Million	0.112x	-21.89%
2020-12-31	CN¥1.76 Billion ≈ $257.91 Million	CN¥251.61 Million ≈ $36.82 Million	0.143x	+24.57%
2019-12-31	CN¥1.57 Billion ≈ $229.52 Million	CN¥179.75 Million ≈ $26.30 Million	0.115x	+229.61%
2018-12-31	CN¥1.34 Billion ≈ $196.11 Million	CN¥46.60 Million ≈ $6.82 Million	0.035x	-49.57%
2017-12-31	CN¥1.16 Billion ≈ $170.11 Million	CN¥80.15 Million ≈ $11.73 Million	0.069x	-57.01%
2016-12-31	CN¥731.02 Million ≈ $106.97 Million	CN¥117.24 Million ≈ $17.16 Million	0.160x	-22.37%
2015-12-31	CN¥645.81 Million ≈ $94.50 Million	CN¥133.42 Million ≈ $19.52 Million	0.207x	+55.00%
2014-12-31	CN¥564.34 Million ≈ $82.58 Million	CN¥75.22 Million ≈ $11.01 Million	0.133x	-56.46%
2013-12-31	CN¥487.44 Million ≈ $71.33 Million	CN¥149.21 Million ≈ $21.83 Million	0.306x	+255.52%
2012-12-31	CN¥442.58 Million ≈ $64.76 Million	CN¥38.11 Million ≈ $5.58 Million	0.086x	-73.22%
2011-12-31	CN¥378.47 Million ≈ $55.38 Million	CN¥121.67 Million ≈ $17.80 Million	0.321x	--

About Ningbo Menovo Pharm Co Ltd

SHG:603538 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.26 Billion

CN¥8.58 Billion CNY

Market Cap Rank

#7922 Global

#1776 in China

Share Price

CN¥25.24

Change (1 day)

-2.21%

52-Week Range

CN¥19.24 - CN¥68.50

All Time High

CN¥68.50